热门资讯> 正文
Qiagen Expands Master Collaboration Agreement with AstraZeneca
2024-08-29 05:31
- 阿斯利康(AZN) 0
- 快而精医药(QGEN) 0
05:31 PM EDT, 08/28/2024 (MT Newswires) -- Qiagen (QGEN) said late Wednesday it is expanding its master collaboration agreement with AstraZeneca (AZN).
Qiagen will use its QIAstat-Dx syndromic testing platform to develop and validate a genotyping assay that will allow specialty care providers to potentially perform genotyping while patients are undergoing routine clinical examination, the company said.
Price: 45.81, Change: +0.02, Percent Change: +0.04
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
